A carregar...
CircRNA_102272 Promotes Cisplatin-Resistance in Hepatocellular Carcinoma by Decreasing MiR-326 Targeting of RUNX2
BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of tumor-associated death in males and females worldwide. HCC is mostly diagnosed at advanced stages and the chemotherapeutic cisplatin is one of the major therapeutic options in the treatment of patients with treating advanced HCC. Des...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7732977/ https://ncbi.nlm.nih.gov/pubmed/33324096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S258230 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|